Cancer researchers attract dollars

Kolltan Pharmaceuticals, among others, have raised large, early stage rounds to develop cancer therapies

24 August 2009•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.